170 related articles for article (PubMed ID: 29899063)
1. CDK6 Antagonizes p53-Induced Responses during Tumorigenesis.
Bellutti F; Tigan AS; Nebenfuehr S; Dolezal M; Zojer M; Grausenburger R; Hartenberger S; Kollmann S; Doma E; Prchal-Murphy M; Uras IZ; Höllein A; Neuberg DS; Ebert BL; Ringler A; Mueller AC; Loizou JI; Hinds PW; Vogl C; Heller G; Kubicek S; Zuber J; Malumbres M; Farlik M; Villunger A; Kollmann K; Sexl V
Cancer Discov; 2018 Jul; 8(7):884-897. PubMed ID: 29899063
[TBL] [Abstract][Full Text] [Related]
2. Naringenin as a potential inhibitor of human cyclin-dependent kinase 6: Molecular and structural insights into anti-cancer therapeutics.
Yousuf M; Shamsi A; Khan S; Khan P; Shahwan M; Elasbali AM; Haque QMR; Hassan MI
Int J Biol Macromol; 2022 Jul; 213():944-954. PubMed ID: 35690164
[TBL] [Abstract][Full Text] [Related]
3. p53 in the game of transposons.
Wylie A; Jones AE; Abrams JM
Bioessays; 2016 Nov; 38(11):1111-1116. PubMed ID: 27644006
[TBL] [Abstract][Full Text] [Related]
4. p53 Inactivation Leads to a Predictable Pattern of Genome Evolution.
Cancer Discov; 2022 Oct; 12(10):2232. PubMed ID: 36018034
[TBL] [Abstract][Full Text] [Related]
5. A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis.
Kollmann K; Heller G; Schneckenleithner C; Warsch W; Scheicher R; Ott RG; Schäfer M; Fajmann S; Schlederer M; Schiefer AI; Reichart U; Mayerhofer M; Hoeller C; Zöchbauer-Müller S; Kerjaschki D; Bock C; Kenner L; Hoefler G; Freissmuth M; Green AR; Moriggl R; Busslinger M; Malumbres M; Sexl V
Cancer Cell; 2016 Aug; 30(2):359-360. PubMed ID: 27505678
[No Abstract] [Full Text] [Related]
6. Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing.
Gerhart SV; Kellner WA; Thompson C; Pappalardi MB; Zhang XP; Montes de Oca R; Penebre E; Duncan K; Boriack-Sjodin A; Le B; Majer C; McCabe MT; Carpenter C; Johnson N; Kruger RG; Barbash O
Sci Rep; 2018 Jun; 8(1):9711. PubMed ID: 29946150
[TBL] [Abstract][Full Text] [Related]
7. Induction of DUSP14 ubiquitination by PRMT5-mediated arginine methylation.
Yang CY; Chiu LL; Chang CC; Chuang HC; Tan TH
FASEB J; 2018 Jun; 32(12):fj201800244RR. PubMed ID: 29920217
[TBL] [Abstract][Full Text] [Related]
8. RIOK1 kinase activity is required for cell survival irrespective of
Hörmann A; Hopfgartner B; Köcher T; Corcokovic M; Krammer T; Reiser C; Bader G; Shi J; Ehrenhöfer K; Wöhrle S; Schweifer N; Vakoc CR; Kraut N; Pearson M; Petronczki M; Neumüller RA
Oncotarget; 2018 Jun; 9(47):28625-28637. PubMed ID: 29983885
[TBL] [Abstract][Full Text] [Related]
9. A multiprotein supercomplex controlling oncogenic signalling in lymphoma.
Phelan JD; Young RM; Webster DE; Roulland S; Wright GW; Kasbekar M; Shaffer AL; Ceribelli M; Wang JQ; Schmitz R; Nakagawa M; Bachy E; Huang DW; Ji Y; Chen L; Yang Y; Zhao H; Yu X; Xu W; Palisoc MM; Valadez RR; Davies-Hill T; Wilson WH; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Rodriguez FJ; Estephan F; Holdhoff M; Kruhlak MJ; Hewitt SM; Thomas CJ; Pittaluga S; Oellerich T; Staudt LM
Nature; 2018 Aug; 560(7718):387-391. PubMed ID: 29925955
[TBL] [Abstract][Full Text] [Related]
10. Cdk6: At the interface of Rb and p53.
Nebenfuehr S; Bellutti F; Sexl V
Mol Cell Oncol; 2018; 5(5):e1511206. PubMed ID: 30263948
[TBL] [Abstract][Full Text] [Related]
11. Prediction of acute myeloid leukaemia risk in healthy individuals.
Abelson S; Collord G; Ng SWK; Weissbrod O; Mendelson Cohen N; Niemeyer E; Barda N; Zuzarte PC; Heisler L; Sundaravadanam Y; Luben R; Hayat S; Wang TT; Zhao Z; Cirlan I; Pugh TJ; Soave D; Ng K; Latimer C; Hardy C; Raine K; Jones D; Hoult D; Britten A; McPherson JD; Johansson M; Mbabaali F; Eagles J; Miller JK; Pasternack D; Timms L; Krzyzanowski P; Awadalla P; Costa R; Segal E; Bratman SV; Beer P; Behjati S; Martincorena I; Wang JCY; Bowles KM; Quirós JR; Karakatsani A; La Vecchia C; Trichopoulou A; Salamanca-Fernández E; Huerta JM; Barricarte A; Travis RC; Tumino R; Masala G; Boeing H; Panico S; Kaaks R; Krämer A; Sieri S; Riboli E; Vineis P; Foll M; McKay J; Polidoro S; Sala N; Khaw KT; Vermeulen R; Campbell PJ; Papaemmanuil E; Minden MD; Tanay A; Balicer RD; Wareham NJ; Gerstung M; Dick JE; Brennan P; Vassiliou GS; Shlush LI
Nature; 2018 Jul; 559(7714):400-404. PubMed ID: 29988082
[TBL] [Abstract][Full Text] [Related]
12. High speed of fork progression induces DNA replication stress and genomic instability.
Maya-Mendoza A; Moudry P; Merchut-Maya JM; Lee M; Strauss R; Bartek J
Nature; 2018 Jul; 559(7713):279-284. PubMed ID: 29950726
[TBL] [Abstract][Full Text] [Related]
13. IL-23 secreted by myeloid cells drives castration-resistant prostate cancer.
Calcinotto A; Spataro C; Zagato E; Di Mitri D; Gil V; Crespo M; De Bernardis G; Losa M; Mirenda M; Pasquini E; Rinaldi A; Sumanasuriya S; Lambros MB; Neeb A; Lucianò R; Bravi CA; Nava-Rodrigues D; Dolling D; Prayer-Galetti T; Ferreira A; Briganti A; Esposito A; Barry S; Yuan W; Sharp A; de Bono J; Alimonti A
Nature; 2018 Jul; 559(7714):363-369. PubMed ID: 29950727
[TBL] [Abstract][Full Text] [Related]
14. Histone arginine methylation by Prmt5 is required for lung branching morphogenesis through repression of BMP signaling.
Li Q; Jiao J; Li H; Wan H; Zheng C; Cai J; Bao S
J Cell Sci; 2018 Jul; 131(14):. PubMed ID: 29950483
[TBL] [Abstract][Full Text] [Related]
15. Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.
Porpaczy E; Tripolt S; Hoelbl-Kovacic A; Gisslinger B; Bago-Horvath Z; Casanova-Hevia E; Clappier E; Decker T; Fajmann S; Fux DA; Greiner G; Gueltekin S; Heller G; Herkner H; Hoermann G; Kiladjian JJ; Kolbe T; Kornauth C; Krauth MT; Kralovics R; Muellauer L; Mueller M; Prchal-Murphy M; Putz EM; Raffoux E; Schiefer AI; Schmetterer K; Schneckenleithner C; Simonitsch-Klupp I; Skrabs C; Sperr WR; Staber PB; Strobl B; Valent P; Jaeger U; Gisslinger H; Sexl V
Blood; 2018 Aug; 132(7):694-706. PubMed ID: 29907599
[TBL] [Abstract][Full Text] [Related]
16. LZTR1 is a regulator of RAS ubiquitination and signaling.
Bigenzahn JW; Collu GM; Kartnig F; Pieraks M; Vladimer GI; Heinz LX; Sedlyarov V; Schischlik F; Fauster A; Rebsamen M; Parapatics K; Blomen VA; Müller AC; Winter GE; Kralovics R; Brummelkamp TR; Mlodzik M; Superti-Furga G
Science; 2018 Dec; 362(6419):1171-1177. PubMed ID: 30442766
[TBL] [Abstract][Full Text] [Related]
17. Functional Dissection of the Enhancer Repertoire in Human Embryonic Stem Cells.
Barakat TS; Halbritter F; Zhang M; Rendeiro AF; Perenthaler E; Bock C; Chambers I
Cell Stem Cell; 2018 Aug; 23(2):276-288.e8. PubMed ID: 30033119
[TBL] [Abstract][Full Text] [Related]
18. LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity.
Bonday ZQ; Cortez GS; Grogan MJ; Antonysamy S; Weichert K; Bocchinfuso WP; Li F; Kennedy S; Li B; Mader MM; Arrowsmith CH; Brown PJ; Eram MS; Szewczyk MM; Barsyte-Lovejoy D; Vedadi M; Guccione E; Campbell RM
ACS Med Chem Lett; 2018 Jul; 9(7):612-617. PubMed ID: 30034588
[TBL] [Abstract][Full Text] [Related]
19. Arginine methyltransferase inhibitor-1 inhibits sarcoma viability
Zhang B; Chen X; Ge S; Peng C; Zhang S; Chen X; Liu T; Zhang W
Oncol Lett; 2018 Aug; 16(2):2161-2166. PubMed ID: 30008914
[TBL] [Abstract][Full Text] [Related]
20. Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution.
Shain AH; Joseph NM; Yu R; Benhamida J; Liu S; Prow T; Ruben B; North J; Pincus L; Yeh I; Judson R; Bastian BC
Cancer Cell; 2018 Jul; 34(1):45-55.e4. PubMed ID: 29990500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
